Pacifica, California
United States
37
2026-06-04
The entities that hold a legal rights for patent applications filed by inventor Powers Jay Patrick:
Jay Patrick Powers from Pacifica, US has applied for patents for these inventions. The list has both pending applications and granted patents:
CHEMOKINE RECEPTOR MODULATORS AND USES THEREOF
#2 | 2024-06-20CHEMOKINE RECEPTOR MODULATORS AND USES THEREOF
#3 | 2023-04-25Oral formulations of CD73 compounds
#4 | 2023-01-262,3,5-TRISUBSTITUTED PYRAZOLO[1,5-A]PYRIMIDINE COMPOUNDS
#5 | 2022-09-01Immunoregulatory agents
#6 | 2022-08-25Substituted quinolinylcyclohexylpropanamide compounds and improved methods for their preparation
#7 | 2022-07-28PROCESSES FOR PREPARING AMINOPYRIMIDINE COMPOUNDS
#8 | 2022-06-02AMORPHOUS AND CRYSTALLINE FORMS OF IDO INHIBITORS
#9 | 2022-04-28SUBSTITUTED QUINOLINYLCYCLOHEXYLPROPANAMIDE COMPOUNDS AND IMPROVED METHODS FOR THEIR PREPARATION
#10 | 2022-01-20Inhibitors of ARG1 and/or ARG2
#11 | 2021-12-02Modulators of 5′-nucleotidase, ecto and the use thereof
#12 | 2021-11-11CD73 inhibitors
#13 | 2021-10-14Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2α
#14 | 2021-09-02Solid forms of an azolopyrimidine compound
#15 | 2021-06-03Pyridone A2R antagonists
#16 | 2021-01-07Modulators of 5′-nucleotidase, ecto and the use thereof
#17 | 2020-12-31PARENTERALLY ADMINISTERED IMMUNE ENHANCING DRUGS
#18 | 2020-07-30CHEMOKINE RECEPTOR MODULATORS AND USES THEREOF
#19 | 2020-07-16Inhibitors of adenosine 5′-nucleotidase
#20 | 2020-04-23Substituted quinolinylcyclohexylpropanamide compounds and improved methods for their preparation
#21 | 2020-04-16Amorphous and crystalline forms of IDO inhibitors
#22 | 2020-03-05Quinazoline-pyridine derivatives for the treatment of cancer-related disorders
#23 | 2020-02-27Inhibitors of CD73-mediated immunosuppression
#24 | 2019-10-10Modulators of 5′-nucleotidase, ecto and the use thereof
#25 | 2019-05-23Chemokine receptor modulators and uses thereof
#26 | 2019-03-28Immunoregulatory agents
#27 | 2019-01-03Immunoregulatory agents
#28 | 2018-11-15IMMUNOREGULATORY AGENTS
#29 | 2018-10-04IMMUNOREGULATORY AGENTS
#30 | 2018-03-15Chemokine receptor modulators and uses thereof
#31 | 2018-03-15Chemokine receptor modulators and uses thereof
#32 | 2017-09-21Modulators of 5′-nucleotidase, ecto and the use thereof
#33 | 2017-07-13Immunoregulatory agents
#34 | 2017-05-25Immunoregulatory agents
#35 | 2017-04-27Immunoregulatory agents
#36 | 2016-05-19Immunoregulatory agents
#37 | 2016-05-19Immunoregulatory agents
1532619 ⎘